research
Clinical Trials and Therapeutics
Treating impulsivity in people with progressive supranuclear palsy
Theme Group:
Funding:
MRC funded
About the project:
Phase 2/3 clinical trial investigating the use of Atomoxetine to treat impulsivity.
Key iDeAC expertise:
Related projects: